Evidence map›Paper›PMID 25074985›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2014

Effects of delayed gastric emptying on postprandial glucose kinetics, insulin sensitivity, and β-cell function.

Ling Hinshaw, Michele Schiavon, Ashwini Mallad, Chiara Dalla Man, Rita Basu, Adil E Bharucha, Claudio Cobelli, Rickey E Carter, Ananda Basu, Yogish C Kudva

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Effect of Pramlintide on Postprandial Glucose Fluxes in Type 1 Diabetes.The Journal of clinical endocrinology and metabolism · 2016
    Trial
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Advances in the physiology of gastric emptying.Neurogastroenterology and motility · 2019
    Review
  12. Gastrointestinal hormones and regulation of gastric emptying.Current opinion in endocrinology, diabetes, and obesity · 2019
    Review
  13. Future of Automated Insulin Delivery Systems.Diabetes technology & therapeutics · 2017
    Review
  14. Relationship between insulin sensitivity and insulin secretion rate: not necessarily hyperbolic.Diabetic medicine : a journal of the British Diabetic Association · 2016
    Article
  15. Article
  16. Article
  17. Article
  18. Insulin:Carbohydrate Ratio--Part of the Story.Diabetes technology & therapeutics · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Ling HinshawDivision of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota;
Michele SchiavonDepartment of Information Engineering, University of Padua, Padua, Italy;
Ashwini MalladDivision of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota;
Chiara Dalla ManDepartment of Information Engineering, University of Padua, Padua, Italy;
Rita BasuDivision of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota;
Adil E BharuchaDivision of Gastroenterology, Mayo Medical School, Rochester, Minnesota; and.
Claudio CobelliDepartment of Information Engineering, University of Padua, Padua, Italy;
Rickey E CarterDepartment of Health Sciences Research, Mayo Medical School, Rochester, Minnesota.
Ananda BasuDivision of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota;
Yogish C KudvaDivision of Endocrinology and Metabolism, Mayo Clinic, Rochester, Minnesota; Kudva.Yogish@mayo.edu.
Mayo Clinic · USUniversity of Padua · ITMayo Clinic in Arizona · USMayo Clinic in Florida · US

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
MECHANISMS OF INSULIN RESISTANCE IN MANR01DK029953 · NIDDK · UNIVERSITY OF VIRGINIA · PI BASU, RITA · 1986 to 2024
$11.5M
TECHNOLOGY NMR SPECTROSCOPYU24DK100469 · NIDDK · MAYO CLINIC ROCHESTER · PI NAIR, K SREEKUMARAN · 2013 to 2017
$9.0M
Integrated Approaches to Close the Loop in Type 1 DiabetesR01DK085516 · NIDDK · UNIVERSITY OF VIRGINIA · PI BASU, ANANDA · 2009 to 2021
$6.5M
Ambulatory Artificial Pancreas: merging physiology, behavior, and control designDP3DK094331 · NIDDK · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI BASU, ANANDA, DOYLE, FRANCIS J · 2011 to 2014
$4.6M
NCATS NIH HHS UL1 TR000135NCATS NIH HHS UL1-TR-000135NIDDK NIH HHS DK-DP3-094331NIDDK NIH HHS DK-R01-085516NIDDK NIH HHS R01 DK029953NIDDK NIH HHS U24 DK100469
6 · The paper itself

Abstract

Controlling meal-related glucose excursions continues to be a therapeutic challenge in diabetes mellitus. Mechanistic reasons for this need to be understood better to develop appropriate therapies. To investigate delayed gastric emptying effects on postprandial glucose turnover, insulin sensitivity, and β-cell responsivity and function, as a feasibility study prior to studying patients with type 1 diabetes, we used the triple tracer technique C-peptide and oral minimal model approach in healthy subjects. A single dose of 30 μg of pramlintide administered at the start of a mixed meal was used to delay gastric emptying rates. With delayed gastric emptying rates, peak rate of meal glucose appearance was delayed, and rate of endogenous glucose production (EGP) was lower. C-peptide and oral minimal models enabled the assessments of β-cell function, insulin sensitivity, and β-cell responsivity simultaneously. Delayed gastric emptying induced by pramlintide improved total insulin sensitivity and decreased total β-cell responsivity. However, β-cell function as measured by total disposition index did not change. The improved whole body insulin sensitivity coupled with lower rate of appearance of EGP with delayed gastric emptying provides experimental proof of the importance of evaluating pramlintide in artificial endocrine pancreas approaches to reduce postprandial blood glucose variability in patients with type 1 diabetes.

Indexed as

AdolescentAdultAlgorithmsBlood GlucoseC-PeptideFemaleFoodGastric EmptyingGlucagonGlucoseHumansHyperglycemiaHypoglycemic AgentsInsulinInsulin ResistanceInsulin-Secreting CellsBlood GlucoseC-PeptideGlucagonGlucoseHypoglycemic AgentsInsulinIslet Amyloid Polypeptidepramlintidegastric emptyinginsulin actionpramlintide

Identifiers

PMID25074985
PMCPMC4166717
OpenAlexW2059830108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.